NCT00791154 2024-08-23
SCLC
NantCell, Inc.
Phase 1/2 Terminated
Clinical Trials
6 trialsNCT05278975 2024-01-26
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
RS Oncology LLC
Phase 1/2 Unknown
NCT05330065 2022-04-15
A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion
The First Affiliated Hospital of Zhengzhou University
Phase 1/2 Unknown
NCT03597009 2021-04-20
A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Terminated
NCT03781908 2018-12-20
Management of Malignant Pleural Effusion With Indwelling Pleural Catheter Versus Silver Nitrate Pleurodesis
Assiut University
Phase 1/2 Unknown
NCT03736122 2018-11-08
A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites
BioSyngen Pte Ltd
Phase 1/2 Unknown